• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Randomized phase III trial of cisplatin/irinotecan versus cisplatin/etoposide in patients with extensive-stage small-cell lung cancer.

作者信息

Lara Primo N, Gandara David R, Natale Ronald B

机构信息

University of California, Davis Cancer Center, Sacramento, CA 95817-2229, USA.

出版信息

Clin Lung Cancer. 2006 Mar;7(5):353-6. doi: 10.3816/CLC.2006.n.019.

DOI:10.3816/CLC.2006.n.019
PMID:16640809
Abstract
摘要

相似文献

1
Randomized phase III trial of cisplatin/irinotecan versus cisplatin/etoposide in patients with extensive-stage small-cell lung cancer.顺铂/伊立替康对比顺铂/依托泊苷用于广泛期小细胞肺癌患者的随机III期试验
Clin Lung Cancer. 2006 Mar;7(5):353-6. doi: 10.3816/CLC.2006.n.019.
2
Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer.伊立替康联合顺铂与依托泊苷联合顺铂治疗广泛期小细胞肺癌的比较。
N Engl J Med. 2002 Jan 10;346(2):85-91. doi: 10.1056/NEJMoa003034.
3
New state of the art in small-cell lung cancer.小细胞肺癌的最新技术水平
Oncology (Williston Park). 2001 Jan;15(1 Suppl 1):8-10.
4
Pilot study of concurrent etoposide and cisplatin plus accelerated hyperfractionated thoracic radiotherapy followed by irinotecan and cisplatin for limited-stage small cell lung cancer: Japan Clinical Oncology Group 9903.依托泊苷和顺铂同步化疗加加速超分割胸部放疗后序贯伊立替康和顺铂治疗局限期小细胞肺癌的前瞻性研究：日本临床肿瘤学会9903研究
Clin Cancer Res. 2005 Aug 1;11(15):5534-8. doi: 10.1158/1078-0432.CCR-04-1771.
5
Randomized phase III trial comparing irinotecan/cisplatin with etoposide/cisplatin in patients with previously untreated extensive-stage disease small-cell lung cancer.一项随机III期试验，比较伊立替康/顺铂与依托泊苷/顺铂用于先前未治疗的广泛期小细胞肺癌患者的疗效。
J Clin Oncol. 2006 May 1;24(13):2038-43. doi: 10.1200/JCO.2005.04.8595.
6
Lung cancer--time to move on from chemotherapy.肺癌——是时候告别化疗了。
N Engl J Med. 2002 Jan 10;346(2):126-8. doi: 10.1056/NEJM200201103460211.
7
Irinotecan-cisplatin therapy for patients with extensive-stage small cell lung cancer: use patterns among American medical oncologists 2000-2006.伊立替康联合顺铂治疗广泛期小细胞肺癌患者：2000 - 2006年美国医学肿瘤学家的使用模式
J Thorac Oncol. 2007 Oct;2(10):953-6. doi: 10.1097/JTO.0b013e318153f8db.
8
Complement and correction for meta-analysis of patients with extensive-stage small cell lung cancer managed with irinotecan/cisplatin versus etoposide/cisplatin as first-line chemotherapy.以伊立替康/顺铂与依托泊苷/顺铂作为一线化疗方案治疗广泛期小细胞肺癌患者的荟萃分析的补充与校正
J Thorac Oncol. 2011 Feb;6(2):406-8; author reply 408. doi: 10.1097/JTO.0b013e3182061d8c.
9
Randomised phase II trial of irinotecan plus cisplatin vs irinotecan, cisplatin plus etoposide repeated every 3 weeks in patients with extensive-disease small-cell lung cancer.伊立替康联合顺铂与伊立替康、顺铂加依托泊苷每3周重复给药用于广泛期小细胞肺癌患者的随机II期试验。
Br J Cancer. 2008 Feb 26;98(4):693-6. doi: 10.1038/sj.bjc.6604233. Epub 2008 Feb 5.
10
Irinotecan plus cisplatin in small-cell lung cancer.伊立替康联合顺铂治疗小细胞肺癌
Oncology (Williston Park). 2002 Sep;16(9 Suppl 9):39-43.

引用本文的文献

1
Randomized phase 2 study comparing irinotecan versus amrubicin as maintenance therapy after first-line induction therapy for extensive disease small cell lung cancer (HOT1401/NJLCG1401).一项随机2期研究，比较伊立替康与氨柔比星作为广泛期小细胞肺癌一线诱导治疗后维持治疗的疗效（HOT1401/NJLCG1401）。
Thorac Cancer. 2021 Jul;12(14):2113-2121. doi: 10.1111/1759-7714.14048. Epub 2021 Jun 2.
2
Randomized-controlled phase II trial of salvage chemotherapy after immunization with a TP53-transfected dendritic cell-based vaccine (Ad.p53-DC) in patients with recurrent small cell lung cancer.TP53 转染树突状细胞疫苗（Ad.p53-DC）免疫治疗后挽救化疗治疗复发性小细胞肺癌的随机对照 II 期试验
Cancer Immunol Immunother. 2019 Mar;68(3):517-527. doi: 10.1007/s00262-018-2287-9. Epub 2018 Dec 27.
3
Comparing the adverse effects of platinum in combination with etoposide or irinotecan in previously untreated small-cell lung cancer patients with extensive disease: A network meta-analyses.比较广泛期未经治疗的小细胞肺癌患者中铂类联合依托泊苷或伊立替康的不良反应：一项网络荟萃分析。
Thorac Cancer. 2017 May;8(3):170-180. doi: 10.1111/1759-7714.12420. Epub 2017 Mar 6.
4
[First-line Chemotherapy for Extensive-disease Small Cell Lung Cancer: 
A Network Meta-analysis].[广泛期小细胞肺癌的一线化疗：网络荟萃分析]
Zhongguo Fei Ai Za Zhi. 2016 Apr 20;19(4):184-91. doi: 10.3779/j.issn.1009-3419.2016.04.02.
5
Platinum versus non-platinum chemotherapy regimens for small cell lung cancer.用于小细胞肺癌的铂类与非铂类化疗方案
Cochrane Database Syst Rev. 2015 Aug 2;2015(8):CD006849. doi: 10.1002/14651858.CD006849.pub3.
6
High-grade neuroendocrine carcinoma of the colon, long-term survival in advanced disease.结肠高级别神经内分泌癌，晚期疾病的长期生存。
Med Oncol. 2011 Dec;28 Suppl 1:S169-74. doi: 10.1007/s12032-010-9674-1. Epub 2010 Sep 14.
7
Features of potentially predictive biomarkers of chemotherapeutic efficacy in small cell lung cancer.小细胞肺癌化疗疗效潜在预测生物标志物的特征。
J Thorac Oncol. 2010 Apr;5(4):484-90. doi: 10.1097/JTO.0b013e3181ccb27b.
8
Novel systemic therapies for small cell lung cancer.小细胞肺癌的新型全身治疗方法。
J Natl Compr Canc Netw. 2008 Mar;6(3):315-22. doi: 10.6004/jnccn.2008.0026.